why choose us

First received: January 27, 2023

Clinical Trial: LEV102 Topical Gel in Acquired Blepharoptosis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Acquired Blepharoptosis

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2a Study of LEV102 Topical Gel in Subjects With Acquired Blepharoptosis

Brief Summary: Phase 1/2a, multicenter, randomized, vehicle-controlled, double-masked, multiple-dose, parallel-group study conducted in adult subjects with acquired blepharoptosis.

Read more